N¹-Methylnicotinamide Improves Hepatic Insulin Sensitivity via Activation of SIRT1 and Inhibition of FOXO1 Acetylation

Figure 1

MNAM can reduce body weight and fasting blood glucose levels in obese type 2 diabetic mice (). (a) Weights of mice in each group; (b) weights of mice at 8 weeks in each group; (c) fasting blood glucose of mice in each group; (d) fasting blood glucose of mice at 8 weeks in each group. Compared with the control group, ; ^#compared with the CMNAM group, ; ^$compared with the DM group, . (e) Average daily food intake of mice at 8 weeks in each group. ns: .

(a)

(b)

(c)

(d)

(e)